212 related articles for article (PubMed ID: 19875242)
1. [In vitro activity of daptomycin against strains isolated from diabetic foot ulcers].
Sotto A; Laouini D; Bouziges N; Jourdan N; Richard JL; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):73-7. PubMed ID: 19875242
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.
Sotto A; Bouziges N; Jourdan N; Richard JL; Lavigne JP
Pathol Biol (Paris); 2007 Nov; 55(8-9):398-406. PubMed ID: 17905534
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
Sader HS; Watters AA; Fritsche TR; Jones RN
BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
Sader HS; Streit JM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):201-4. PubMed ID: 15541606
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
Bell JM; Turnidge JD; Sader HS; Jones RN
Pathology; 2010; 42(5):470-3. PubMed ID: 20632825
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
[TBL] [Abstract][Full Text] [Related]
10. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
Sader HS; Streit JM; Fritsche TR; Jones RN
Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
[TBL] [Abstract][Full Text] [Related]
12. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
Castanheira M; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):235-9. PubMed ID: 18314293
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):329-32. PubMed ID: 16263233
[TBL] [Abstract][Full Text] [Related]
14. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):417-22. PubMed ID: 23514757
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of ertapenem against strains isolated from diabetic foot infections].
Sotto A; Lemaire X; Jourdan N; Bouziges N; Richard JL; Lavigne JP
Med Mal Infect; 2008 Mar; 38(3):146-52. PubMed ID: 18191514
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
Dhawan B; Gadepalli R; Kapil A
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):196-8. PubMed ID: 19748433
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
Malli E; Spiliopoulou I; Kolonitsiou F; Klapsa D; Giannitsioti E; Pantelidi K; Pratti A; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Frantzidou F; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou ED; Petinaki E
Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268
[TBL] [Abstract][Full Text] [Related]
20. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]